PILESEPTINE SPRAY: Effective Relief for External Hemorrhoids
The PILESEPRINE SPRAY is a non-invasive treatment for external hemorrhifers, designed to create a protective barrier, cleanse the area, and trigger cell growth and healing. It has shown to reduce pain by 75%, irritation by 57%, and rect. It also reduces the risk of infection by 75%, and significantly reduces the discomfort of defecation. It is a safe and effective alternative to conventional treatments.


PILESEPTINE SPRAY: An Innovative Solution for External Hemorrhoids
Introduction to PILESEPTINE SPRAY
The PILESEPTINE SPRAY is a specially designed treatment for external hemorrhoids, also known as piles. This medical device comes in a 30 ml spray tube and is designed to create a filmogenic liquid bandage that targets and binds to inflammatory proteins, contaminants, and impurities.
Threefold Action of PILESEPTINE SPRAY
The product works in three main ways:
Protective Barrier Effect
The spray creates a protective barrier that shields the mucous membranes from further irritation and damage.
Osmotic and Cleaning Effect
The high osmotic activity of the spray instantly attracts and traps most of the adhered contaminants. This suppresses inflammation and the immune cascade, providing immediate relief.
Cellular Repair and Growth Effect
Once the area is clean and hydrated, the body can immediately trigger cell growth and healing, further reducing discomfort and promoting recovery.
Clinical Trial Results: Efficacy of PILESEPTINE SPRAY
In a randomized, double-blind, placebo-controlled trial over two weeks with 54 patients (37 using the test product and 17 using a placebo), the PILESEPTINE SPRAY showed significant results.
Pain and Irritation Reduction
Pain intensity reduced by 14.23% within 2 hours and 75.03% within 21 days. Irritation reduced by 14.34% within 2 hours and 57.93% within 14 days.
Reduction in Rectal Bleeding and Improved Lesion Hydration
Rectal bleeding reduced by 23.83% within 2 hours and 75.46% within 14 days. The spray also improved lesion hydration by 36.23% within 2 days and 85.01% within 14 days.
Decreased Discomfort during Defecation
Discomfort during defecation reduced by about 20% within 2 days and about 80% within 14 days.
Conclusion: The Effectiveness of PILESEPTINE SPRAY
These results highlight the effectiveness of the PILESEPTINE SPRAY in treating external hemorrhoids.
Understanding External Hemorrhoids: Causes, Symptoms, and Management
What are External Hemorrhoids?
External hemorrhoids are a common condition that occurs when the blood vessels around the anus and lower rectum become swollen and inflamed. This can lead to a range of uncomfortable symptoms.
Symptoms of External Hemorrhoids
Patients with this condition may experience discomfort, itching, and pain. In some cases, bleeding may occur during bowel movements, adding to the discomfort.
Causes of External Hemorrhoids
External hemorrhoids are usually caused by increased pressure in the lower rectum. This pressure can be due to a variety of factors such as straining during bowel movements, sitting for long periods, obesity, pregnancy, or a low-fiber diet.
Impact on Quality of Life and the Importance of Treatment
While not usually serious, external hemorrhoids can be uncomfortable and may affect the quality of life. However, with proper treatment and lifestyle changes, most people can effectively manage their symptoms and prevent the condition from worsening. This highlights the importance of understanding the condition and seeking appropriate treatment.
PILESPETINE SPRAY Randomized, double-blind clinical trial
General informations
Title : Clinical Efficacy of a Dual Action, Topical Anti-edematous and Anti-inflammatory Device for the Treatment of External Hemorrhoids
Journal : Clinical Trial | 2018
Patients: N=54 | Test product = 37 ; Comparator = 17
Duration : 2 weeks
Inclusion : having clinical manifestations of grade I to III external hemorrhoids
Link : 11-External-hemorrhoids-J-Clin-Exp-Phar-2018
Main results
PAIN
• 14,23 % reduction in intensity of pain within 2 hours.
• 23,29 % reduction in intensity of pain within 2 days, compare to CP.
• 32,81 % reduction in intensity of pain within 3 days, compare to CP.
• 45,87 % reduction in intensity of pain within 8 days, compare to CP.
• 62,36 % reduction in intensity of pain within 14 days, compare to CP.
• 75,03 % reduction in intensity of pain within 21 days, compare to CP.
IRRITATION
• 14,34 % reduction in irritation within 2 hours.
• 19,15 % reduction in irritation within 2 days, compare to CP.
• 30,12 % reduction in irritation within 3 days, compare to CP.
• 43,73 % reduction in irritation within 8 days, compare to CP.
• 57,93 % reduction in irritation within 14 days, compare to CP.
RECTAL BLEEDING
• 23,83 % reduction in rectal bleeding within 2 hours.
• 23,85 % reduction in rectal bleeding within 2 days, compare to CP.
• 43,95 % reduction in rectal bleeding within 3 days, compare to CP.
• 58,89 % reduction in rectal bleeding within 8 days, compare to CP.
• 75,46 % reduction in rectal bleeding within 14 days, compare to CP.
• 77,77 % reduction in rectal bleeding within 21 days, compare to CP.
HYDRATATION
• 36,23 % improvement in lesion hydratation within 2 days, compare to CP.
• 48,04 % improvement in lesion hydratation within 3 days, compare to CP.
• 71,69 % improvement in lesion hydratation within 8 days, compare to CP.
• 85,01 % improvement in lesion hydratation within 14 days, compare to CP.
DEFECATE DISCOMFORT
• About 20 % reduction in defecate discomfort within 2 days.
• About 40 % reduction in defecate discomfort within 3 days.
• About 60 % reduction in defecate discomfort within 8 days.
• About 80 % reduction in defecate discomfort within 14 days.
Indication | Filmogen liquid bandage for the treatment of external hemorrhoids (piles). |
Composition | Filmogenic glycerol, water, association of Vaccinium macrocarpon, Vitris vinifera, EO : Mentha piperita. |
Presentation | Tube 30ml |
Class | MDD Class IIa | MDR Class IIa |
Direction | Apply in wounds, 2-3 times a day. |
Precautions | The product is intended for topical use only (damage mucosa surface) and should not be swallowed. Keep out of reach and sight of children. |
Age | 18+ |
Storage conditions | Below 25°C |
Legal manufacturer | VITROBIO (France) |
Product code | PIE |